Market News & Trends
Sernova Announces Agreement With CCRM to Produce Specialized Cells for Diabetes Treatment
Sernova Corp recently announced it has entered into a service agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to establish, optimize, and validate…
Noxilizer Announces New Senior Vice President & CFO
Noxilizer, Inc., the company advancing a room temperature, NO2-based sterilization and decontamination process for biopharmaceutical and medical device manufacturers recently announced David A. Theil as…
AbCellera & Merck Sign Novel Therapeutic Antibody Discovery Collaboration
AbCellera recently announced a new collaboration with Merck, known as MSD outside the United States and Canada, through a subsidiary, to generate antibodies against an…
Catalent & Cerenis Therapeutics Announce Phase III Trial of CER-001
Catalent Pharma Solutions recently announced that Cerenis Therapeutics has advanced its leading clinical candidate, CER-001, into Phase III clinical studies across Europe and North America.…
Fibrocell Science Highlights Recent Pipeline Accomplishments
Fibrocell Science, Inc. recently highlighted several recent accomplishments related to the continued advancement of the company’s pipeline. “Recently, Fibrocell has made significant progress across our…
Global Orphan Drug Market to Gain Almost $68 Billion by 2019; Favorable Legislation Spurring R&D
Growing competition, new technologies, improved gene therapies, and favorable legislation and incentives have led the global orphan drug market to experience a significant increase in…
RNAi Therapeutics Holds Therapeutic Promise for Unmet Conditions
Ribonucleic acid interference (RNAi) mechanisms and technologies are being extensively explored in biological applications in order to silence mRNA’s encoding proteins and to develop appropriate…
Pharma Companies Must Assess Real-World Evidence to Keep Up With Shifts in the Global Market Access Landscape
As the overall costs of drugs continue to increase and pricing pressures shift the dynamics of the healthcare market, pharmaceutical companies must analyze real-world trends…
GeneOne Life Science & Inovio Pharmaceuticals to Collaborate on Zika Virus Vaccine Development
GeneOne Life Science recently announced the initiation of a collaborative research program with Inovio Pharmaceuticals to test and advance a DNA-based vaccine for preventing and…
Polyganics & MicroAire Sign Exclusive Distribution Agreement
Polyganics recently announced it has signed an exclusive distribution agreement with its strategic partner MicroAire Surgical Instruments LLC for the company’s entire peripheral nerve repair…
SGS Life Sciences Announces Major Expansion & Integration Following Acquisition
SGS recently announced that further to the acquisition of Quality Compliance Laboratories Inc. (QCL) in December 2015, its global network now offers chemistry and microbiology…
Collegium Announces FDA Acceptance of IND Application for Abuse-Deterrent Analgesic
Collegium Pharmaceutical, Inc. recently announced the US FDA has accepted the company’s investigational new drug (IND) application to begin a clinical trial of Hydrocodone DETERx®,…
HERMES PHARMA Makes Hot-Melt Coating Available for the Pharma Industry
HERMES PHARMA, the expert in user-friendly solid oral dosage forms, recently announced the commercial implementation of hot-melt coating (HMC) in its production facility.…
Catalent to Open New Clinical Supply Facility in Japan
Catalent Pharma Solutions recently announced that it is to introduce clinical supply services at its 200,000-sq-ft cGMP facility in Kakegawa, Japan. The site, which has…
BioXcel Strengthens Position in Immuno-Oncology With Dedicated Big Data Analytics Platform
BioXcel Corporation recently announced the launch of its first in class PharmGPS Oncology and Immuno-Oncology Suite. The platform’s comprehensive big data approach provides industry stakeholders…
Case Study of Formulating “One & Done” Daily Dosing Involving a Highly Water-Soluble API
By: Michael DeHart, PhD The Issue Metrics Contract Services was approached by a client with a commercialized drug product indicated…
Catalent Biologics Announces Collaboration With Roche on SMARTag Technology
Catalent, Inc., the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, recently announced, through its wholly…
Sucampo Enters Exclusive Option & Collaboration Agreement With Cancer Prevention Pharmaceuticals
Sucampo Pharmaceuticals, Inc. recently announced an option and collaboration agreement under which Cancer Prevention Pharmaceuticals, Inc. (CPP) has granted Sucampo the sole option to acquire…
ProImmune Introduces ProT2 MHC Class II Tetramer Reagents to Study Antigen-Specific CD4+ T Cell Immune Responses
ProImmune recently announced the introduction of ProT2, a range of Human MHC Class II tetramer reagents for tetramer analyses in the study of antigen-specific CD4+…
California Institute for Biomedical Research Enters Worldwide Strategic Collaboration With Pfizer
The California Institute for Biomedical Research (Calibr), a non-profit translational research institute, recently announced it has entered into a global strategic collaboration with Pfizer Inc.…
